Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-3948
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration ; day:15 ; month:9 ; year:2020 ; pages:1-9
Drug Delivery and Translational Research ; (15.9.2020), 1-9
- Creator
-
Ramirez, Gisela
Pham, Anna C.
Clulow, Andrew J.
Salim, Malinda
Hawley, Adrian
Boyd, Ben J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13346-020-00851-z
- URN
-
urn:nbn:de:101:1-2020110322115804778882
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ramirez, Gisela
- Pham, Anna C.
- Clulow, Andrew J.
- Salim, Malinda
- Hawley, Adrian
- Boyd, Ben J.
- SpringerLink (Online service)
Other Objects (12)
Comparative absorption of curcumin formulations
Development of sustained release formulations for phytopharmaceuticals
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Crystalline monoclonal antibodies : development of stable crystals for drying and sustained release formulations
Crystalline Monoclonal Antibodies: Development of stable crystals for drying and sustained release formulations
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers
Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody
Comparison of nitrous acid detection using open-path incoherent broadband cavity-enhanced absorption spectroscopy and extractive long-path absorption photometry
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Field measurements of water continuum and water dimer absorption by active long path differential optical absorption spectroscopy (DOAS)
Comparative absorption of curcumin formulations
Development of sustained release formulations for phytopharmaceuticals
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Crystalline monoclonal antibodies : development of stable crystals for drying and sustained release formulations
Crystalline Monoclonal Antibodies: Development of stable crystals for drying and sustained release formulations
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers
Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody
Comparison of nitrous acid detection using open-path incoherent broadband cavity-enhanced absorption spectroscopy and extractive long-path absorption photometry
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Field measurements of water continuum and water dimer absorption by active long path differential optical absorption spectroscopy (DOAS)
Comparative absorption of curcumin formulations
Development of sustained release formulations for phytopharmaceuticals
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Crystalline monoclonal antibodies : development of stable crystals for drying and sustained release formulations
Crystalline Monoclonal Antibodies: Development of stable crystals for drying and sustained release formulations
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers
Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody
Comparison of nitrous acid detection using open-path incoherent broadband cavity-enhanced absorption spectroscopy and extractive long-path absorption photometry
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations